Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Liminatus Pharma(LIMN) the EBIT is -1.379 M (-23.31%);the EPS is -1.45 (-698.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B23.31%
----
----
EPS
-1.4538698.06%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf